ARCHIVES

Amgen Pays $24.9 Million To Settle Kickback Charges

This article is from The Cancer Letter archive.

Vol. 39 No. 16 | April 19, 2013

Download PDF Visit The Full Archive

Related Articles

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

New Community Center Assnt. Determined To Improve Quality Of Care “With Or Without” NCI Assistance

September 27, 1974

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies

August 5, 1988

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979